Microbot Medical (MBOT) Cash from Investing Activities (2010 - 2026)

Microbot Medical (MBOT) has 17 years of Cash from Investing Activities data on file, last reported at $5.0 million in Q1 2026.

• Quarterly Cash from Investing Activities rose 120.12% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$42.6 million (down 93.36% YoY) and the FY2025 annual result came in at -$72.4 million, down 4809.43% from the prior year.
• Cash from Investing Activities advanced to $5.0 million in Q1 2026, from -$1.5 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $5.0 million in Q1 2026 to a low of -$44.7 million in Q3 2025.
• A 5-year average of -$4.0 million and a median of -$62000.0 in 2022 frame the typical range for Cash from Investing Activities.
• The widest YoY moves for Cash from Investing Activities: up 18118.75% in 2023, down 51340.0% in 2023.
• Tracing MBOT's Cash from Investing Activities over 5 years: stood at -$3.8 million in 2022, then soared by 178.79% to $3.0 million in 2023, then slumped by 49.44% to $1.5 million in 2024, then tumbled by 202.54% to -$1.5 million in 2025, then jumped by 425.96% to $5.0 million in 2026.
• The last three Cash from Investing Activities figures came in at $5.0 million (Q1 2026), -$1.5 million (Q4 2025), and -$44.7 million (Q3 2025), per Business Quant data.